{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:36:05Z","timestamp":1793133365323,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,7]],"date-time":"2027-10-07T00:00:00Z","timestamp":1822867200000},"content-version":"am","delay-in-days":279,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["R25HG012919"],"award-info":[{"award-number":["R25HG012919"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR070879"],"award-info":[{"award-number":["AR070879"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bone.2026.118122","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:30:59Z","timestamp":1791041459000},"page":"118122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bone response to intermittent parathyroid hormone (PTH) is both genetic and sex specific in mice"],"prefix":"10.1016","volume":"214","author":[{"given":"Douglas J.","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana A.","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane E.","family":"Ridoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Maynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole S.","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan M.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Ackert-Bicknell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bone.2026.118122_bb0005","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1210\/jc.2002-020334","article-title":"A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis","volume":"87","author":"Body","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2026.118122_bb0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ecl.2024.08.003","article-title":"Latest on anabolic agents for osteoporosis treatment","volume":"53","author":"di Filippo","year":"2024","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"6","key":"10.1016\/j.bone.2026.118122_bb0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1742-7843.2004.pto940602.x","article-title":"Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis","volume":"94","author":"Brixen","year":"2004","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.bone.2026.118122_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10800","article-title":"Anabolic and antiresorptive osteoporosis treatment: trends, costs, and sequence in a commercially insured population, 2003-2021","volume":"7","author":"Wadhwa","year":"2023","journal-title":"JBMR Plus."},{"issue":"12","key":"10.1016\/j.bone.2026.118122_bb0025","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years","volume":"27","author":"Andrews","year":"2012","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2026.118122_bb0030","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.bone.2006.06.007","article-title":"Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis","volume":"39","author":"Gallagher","year":"2006","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2026.118122_bb0035","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00198-010-1376-1","article-title":"Variability in the measured response of bone to teriparatide","volume":"22","author":"Heaney","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2026.118122_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bonr.2015.11.001","article-title":"Predictors of teriparatide treatment failure in patients with low bone mass","volume":"4","author":"Elraiyah","year":"2016","journal-title":"Bone Rep."},{"issue":"3","key":"10.1016\/j.bone.2026.118122_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/07435800.2018.1454461","article-title":"Skeletal response to treatment with teriparatide (TPD) after bisphosphonate in post-menopausal women with osteoporosis and a high prevalence of secondary risk factors in real-life setting of a metabolic bone clinic; effect of age and vitamin D status","volume":"43","author":"Mok","year":"2018","journal-title":"Endocr. Res."},{"issue":"3","key":"10.1016\/j.bone.2026.118122_bb0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11914-013-0151-6","article-title":"Impact of the environment on the skeleton: is it modulated by genetic factors?","volume":"11","author":"Ackert-Bicknell","year":"2013","journal-title":"Curr. Osteoporos. Rep."},{"issue":"7","key":"10.1016\/j.bone.2026.118122_bb0055","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/ard-2022-223618","article-title":"Genome-wide association study identifies genetic variants which predict the response of bone mineral density to teriparatide therapy","volume":"82","author":"Alonso","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.bone.2026.118122_bb0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/gepi.20398","article-title":"Quantifying and correcting for the winner\u2019s curse in genetic association studies","volume":"33","author":"Xiao","year":"2009","journal-title":"Genet. Epidemiol."},{"issue":"7","key":"10.1016\/j.bone.2026.118122_bb0065","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/aje\/kwx227","article-title":"Current challenges and new opportunities for gene-environment interaction studies of complex diseases","volume":"186","author":"McAllister","year":"2017","journal-title":"Am. J. Epidemiol."},{"issue":"9\u201310","key":"10.1016\/j.bone.2026.118122_bb0070","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00335-012-9414-2","article-title":"The diversity outbred mouse population","volume":"23","author":"Churchill","year":"2012","journal-title":"Mamm. Genome"},{"issue":"11","key":"10.1016\/j.bone.2026.118122_bb0075","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ng1104-1133","article-title":"The collaborative cross, a community resource for the genetic analysis of complex traits","volume":"36","author":"Churchill","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2026.118122_bb0080","series-title":"Mouse Genetics: Concepts and Applications [Internet]","author":"Silver","year":"1995"},{"key":"10.1016\/j.bone.2026.118122_bb0085","unstructured":"The Jackson Laboratory Handbook on Genetically Standardized Mice - National Institutes of Health [Internet]. [cited 2026 Aug 24]. Available from: https:\/\/onesearch.nihlibrary.ors.nih.gov\/discovery\/fulldisplay\/alma991000558099704686\/01NIH_INST:NIH."},{"issue":"2","key":"10.1016\/j.bone.2026.118122_bb0090","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bone.2008.04.012","article-title":"Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice","volume":"43","author":"Sugiyama","year":"2008","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2026.118122_bb0095","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bone.2007.11.017","article-title":"Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation","volume":"42","author":"Pettway","year":"2008","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2026.118122_bb0100","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bone.2006.09.010","article-title":"Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity","volume":"40","author":"Iida-Klein","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.118122_bb0105","article-title":"Intermittent fasting alleviates obesity-associated impairments in bone fracture healing: exploring the role of gut microbiome","volume":"27","author":"Hendesi","year":"2025","journal-title":"Bone Rep."},{"issue":"8","key":"10.1016\/j.bone.2026.118122_bb0110","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jbmr\/zjag001","article-title":"IRE1 signaling in osteoprogenitors augments \u03b2-catenin activity and physiologic bone accrual","volume":"41","author":"Kolora","year":"2026","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.118122_bb0115","article-title":"Demystifying machine learning approaches in digital bone imaging using microCT and HRpQCT","volume":"29","author":"David","year":"2026","journal-title":"Bone Rep."},{"issue":"2","key":"10.1016\/j.bone.2026.118122_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11914-018-0421-4","article-title":"Screening gene knockout mice for variation in bone mass: analysis by \u03bcCT and Histomorphometry","volume":"16","author":"Rowe","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"issue":"8","key":"10.1016\/j.bone.2026.118122_bb0125","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1101\/gr.113886.110","article-title":"Genetic analysis in the collaborative cross breeding population","volume":"21","author":"Philip","year":"2011","journal-title":"Genome Res."},{"issue":"9","key":"10.1016\/j.bone.2026.118122_bb0130","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1534\/g3.114.013748","article-title":"Quantitative trait locus mapping methods for diversity outbred mice","volume":"4","author":"Gatti","year":"2014","journal-title":"G3 (Bethesda, Md.)"},{"issue":"8","key":"10.1016\/j.bone.2026.118122_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/genes13081472","article-title":"Analysis of common SNPs across continents reveals major genomic differences between human populations","volume":"13","author":"Fedorova","year":"2022","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.bone.2026.118122_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/jpm9030040","article-title":"Pharmacogenomic testing: clinical evidence and implementation challenges","volume":"9","author":"Hippman","year":"2019","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.bone.2026.118122_bb0145","doi-asserted-by":"crossref","DOI":"10.1007\/s40520-025-02972-2","article-title":"Treatment failure in osteoporosis: who will experience a new fracture? Tailor a retrospective study","volume":"37","author":"Buondonno","year":"2025","journal-title":"Aging Clin. Exp. Res."},{"issue":"12","key":"10.1016\/j.bone.2026.118122_bb0150","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-012-2093-8","article-title":"Treatment failure in osteoporosis","volume":"23","author":"Diez-Perez","year":"2012","journal-title":"Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA."},{"issue":"2","key":"10.1016\/j.bone.2026.118122_bb0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jbmr.563","article-title":"Genome-wide association of an integrated osteoporosis-related phenotype: is there evidence for pleiotropic genes?","volume":"27","author":"Karasik","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2026.118122_bb0160","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1210\/jc.2009-2406","article-title":"Genetic determinants of bone density and fracture risk\u2014state of the art and future directions","volume":"95","author":"Duncan","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2026.118122_bb0165","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1210\/jc.2014-1041","article-title":"Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study","volume":"99","author":"Nishiyama","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2026.118122_bb0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbmr.2315","article-title":"Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study","volume":"30","author":"Tsai","year":"2015","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2026.118122_bb0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2026.118122_bb0180","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00198-014-3001-1","article-title":"Analysis of daily teriparatide treatment for osteoporosis in men","volume":"26","author":"Niimi","year":"2015","journal-title":"Osteoporos. Int."},{"issue":"6","key":"10.1016\/j.bone.2026.118122_bb0185","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tem.2024.01.004","article-title":"A perspective on muscle phenotyping in musculoskeletal research","volume":"35","author":"Foessl","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bone.2026.118122_bb0190","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae153","article-title":"Sexual dimorphism in the musculoskeletal system: sex hormones and beyond","volume":"8","author":"Plotkin","year":"2024","journal-title":"J. Endocr. Soc."},{"issue":"19","key":"10.1016\/j.bone.2026.118122_bb0195","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2026.118122_bb0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mce.2018.06.011","article-title":"Site-specific differences in osteoblast phenotype, mechanical loading response and estrogen receptor-related gene expression","volume":"477","author":"Gharibi","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2026.118122_bb0205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00198-012-2159-7","article-title":"Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women","volume":"24","author":"Shiraki","year":"2013","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2026.118122_bb0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1359\/jbmr.1999.14.1.39","article-title":"Osteoclast formation in bone marrow cultures from two inbred strains of mice with different bone densities","volume":"14","author":"Linkhart","year":"1999","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2026.118122_bb0220","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00198-010-1226-1","article-title":"Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis","volume":"22","author":"Macdonald","year":"2011","journal-title":"Osteoporos. Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226003480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226003480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:27:53Z","timestamp":1793132873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226003480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":43,"alternative-id":["S8756328226003480"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.118122","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone response to intermittent parathyroid hormone (PTH) is both genetic and sex specific in mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.118122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118122"}}